Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern for a period of 12 months from the date of this filing.”View the 10-Q filed Aug 18, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
Cosmos Health expects Q4 2026 U.S. revenue of approximately $15 million and gross profit of approximately $10.5 million, while active U.S. subscriptions reached 8,940 as of October 19, 2026. It reaffirmed full-year 2026 revenue above $90 million.
Cosmos Health Inc. reported preliminary nine-month revenue of approximately $54.3 million, up 19% from $45.6 million, and record third-quarter revenue of approximately $17.4 million. It reaffirmed full-year 2026 revenue expected to surpass $90 million.
